2024-10-20 09:22:51
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.
Corporate/ 2023-07-23
Pivotal phase III clinical trial IND sub...

SHENZHEN,China,Jan. 11,2021-- On January 8,2021,Shenzhen Chipscreen Biosciences Co.,Ltd. (Chipscreen Biosciences,Stock Symbol: 688321.SH)sub...

Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma
Corporate/ 2023-07-23
Korea Fair Trade Commission Assigns Comp...

SEOUL,South Korea,Jan. 11,2021-- Yuyu Pharma (CEO Robert Wonsang Yu,KRX: 000220) received Compliance Program (CP) Rating of "A" fr...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release